Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer (British Journal of Cancer, 2024)

(untitled) - Mah, CY; Nguyen, ADT; Niijima, T; Helm, M; Dehairs, J; Ryan, FJ; Ryan, N; Quek, L; Hoy, AJ; Don, AS; Mills, IG; Swinnen, JV; et al.